Welcure Drugs & Pharmaceuticals secured two new export-sourcing orders worth Rs 85.60 crore. The company has secured orders from Giant Exim and Ravina International, each valuing Rs 42.80 crore for procurement & consolidation of mycorrhizal inoculant (bulk bags) on an EXW basis. The commission income will be recognised on dispatch of each lot and is expected to enhance margins in the current quarter.
The company is in advanced discussions with additional international buyers for similar export sourcing mandates and expects to conclude further orders worth Rs 20 crore or more within the ongoing quarter.
Welcure Drugs & Pharmaceuticals is engaged in the business of manufacture and marketing of pharmaceuticals formulations in the form of tablets, capsules and dry syrups.
| Company Name | CMP |
|---|---|
| Redington | 220.95 |
| Adani Enterprises | 2088.20 |
| Amrapali Industries | 17.32 |
| Rashi Peripheral | 404.30 |
| PDS | 295.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: